SynthesisEuropean journal of clinical pharmacology2024

Quantitative evaluation of the efficacy and safety profiles of two types of targeted inhibitors combined with endocrine therapy in ER+/HER2- metastatic breast cancer.

Meiyu Pan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.